David Y. Liu - 28 Feb 2022 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Chief Scientific Officer
Signature
/s/ Donald A. Kalkofen, Attorney-in-Fact for David Y. Liu
Issuer symbol
PTGX
Transactions as of
28 Feb 2022
Net transactions value
-$51,449
Form type
4
Filing time
02 Mar 2022, 19:38:59 UTC
Previous filing
17 Feb 2022
Next filing
17 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Tax liability $51,449 -2,119 -3.1% $24.28 66,538 28 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 6,125 vested restricted stock units on February 28, 2022.